Centrient Pharmaceuticals, a global leader in sustainable B2B manufacturing of antibiotics, statins, and antifungals, has officially joined the United Nations Global Compact (UNGC), the world’s largest corporate sustainability initiative...
Indian drug makers have been alerted as there are potential tariffs that the US may impose against India regarding oil trade with Russia. Pharmaceutical imports have so far escaped the 25% tariff back in the Trump administration on the grounds...
The National Award for Emerging State in Organ Donation has been awarded to Odisha in recognition of its growing leadership and significant development in organ transplantation and public health education.
The Authentication Solution Providers’ Association (ASPA), the leading industry body dedicated to anti-counterfeiting and traceability, presented a thought leadership paper
As part of a recent examination, the regulator Subject Expert Committee (SEC), under the Central Drugs Standard Control Organisation (CDSCO), directed Akum Pharmaceuticals to submit supportive safety data
The Government of Karnataka state has made a formal notification to merge the AYUSH Drug Licensing Authority, Drug Enforcement Division, and Drug Testing Laboratories in the State Food and Drug Administration
Hyderabad pharmaceutical company Aurobindo Pharma said on July 30 that its US-based unit, Aurobindo Pharma USA Inc., has signed a binding agreement to buy Lannett Company LLC
The much-proposed 25% general tariff, which US President Donald Trump revealed on August 1, 2025, will exempt Indian drug exports to the US. But the mood is far from festive.
Merck & Co. has initiated a major cost-cutting program that will save $3 billion by 2027. The multiyear program of optimization, outlined in its Q2 2025 earnings announcement
The Central Drugs Standard Control Organisation (CDSCO) has introduced a QR Code-based appointment booking for stakeholders visiting CDSCO’s headquarters located in the FDA Bhawan at New Delhi